Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells, according to a new study published in Nanoscale. The study, conducted in partnership by researchers at Nemours Children’s Hospital and the University of Central Florida, demonstrates a potentially novel treatment for neuroblastoma, the most common cancer in infants.
“High-risk neuroblastoma can be resistant to traditional therapy, and survival can be poor. This research demonstrates a novel method of treating this tumor without the toxicity of aggressive therapy that can also have late effects on the patient’s health,” said Tamarah J. Westmoreland, MD, PhD, a pediatric surgeon at Nemours Children’s Health System and senior author of the study. “Unique approaches to target tumor cells with nanoparticle delivery systems hold promise for treatment of resistant tumors, such as the high risk neuroblastoma. We are hopeful that in the future, nanoparticles can be utilized to personalize care to patients and reduce the late effects of therapy.”
Neuroblastomas are cancers that start in early nerve cells and commonly form in the tissue of the adrenal glands, near the kidneys. About 700 new cases of neuroblastoma are diagnosed each year in the United States and most cases appear in children younger than 5 years old. High-risk neuroblastoma is hard to cure and is more likely to become resistant to standard therapies or recur. These cancers are also associated with late effects after treatments have ended, including developmental delays, hearing loss, or other disabilities.
Curcumin has been shown to have substantial anti-cancer ability, but its low solubility and poor stability have made its use in medicinal applications challenging. Researchers from Nemours and UCF found that nanoparticles can be used to deliver curcumin to tumor sites.
“This shows that nanoparticles can be an effective delivery vehicle for cancer drugs,” said Professor Sudipta Seal, who directs of UCF’s NanoScience Technology Center and Advanced Materials Processing Analysis Center, and is a collaborator on the study. “More research is needed, but we are hopeful it could lead to more effective treatment of this devastating disease in the future.”
In the study, researchers loaded Cerium oxide nanoparticles with curcumin and coated them with dextran to test in cell lines of a high-risk form of neuroblastoma, known as MYCN-amplified, as well as non-amplified neuroblastoma. This formulation induced substantial cell death in neuroblastoma cells while producing no or only minor toxicity in healthy cells. Overall, the nano-therapeutic treatments showed a more pronounced effect in MYCN-amplified cells, which are traditionally more resistant to drug therapies.
Nanoscience research, which explores the unusual properties of materials at the nanoscale, has led to advancements in medicine, energy, information storage, computing and other fields. At no more than 100 nanometers, nanoparticles are exceedingly small. By comparison, a sheet of paper is about 75,000 nanometers thick.
This study was conducted in a laboratory setting in Orlando, at Nemours Children’s Hospital and the University of Central Florida in cells from children with neuroblastoma, but researchers hope to begin to use these curcumin nanoparticles with micro RNA in animal models to direct the molecule to a tumor site.
The Latest on: Neuroblastoma
- Decreased Speech and Jerky Eye Movements in a 'Clumsy' Toddleron September 2, 2021 at 2:06 pm
A 28-month-old girl has become irritable and 'clingy.' Her mother reports chaotic, jerky eye movements, decreased speech, and increased clumsiness. Can you make the diagnosis?
- Mum desperate to make memories with son, 4, as he's given 50% chance of surviving canceron September 2, 2021 at 8:03 am
Roxanne Pannell wants to buy a tent so she can take her huge family on holiday after her son George was diagnosed with a rare form of cancer - called neuroblastoma - last year ...
- Dad and daughter's superhike from Greater Manchester to Mancetter to help boy, 5, with canceron August 29, 2021 at 9:53 pm
Gary, who lives in Bolton in north west England, is childhood friends with Kyle's dad Lee and when he heard about the five-year-old's battle against stage 4 Neuroblastoma, a rare and aggressive ...
- A Conversation With Devon and Leah Still: Partnership With United Therapeuticson August 27, 2021 at 11:16 am
September is Childhood Cancer Awareness Month. Devon and Leah Still have partnered with United Therapeutics to raise awareness.
- Cincy Jungle special: Interview with Devon and Leah Stillon August 26, 2021 at 5:05 am
The Orange and Black Insider is pleased to be joined by special guests Devon and Leah Still, as they team up with United Therapeutics Oncology for their "Braving NeuroBLASToma" initiative. We ...
- ALK Inhibitor Success Prompts Search for a Role Beyond NSCLCon August 25, 2021 at 7:25 am
The rapid development of novel agents directed at anaplastic lymphoma kinase gene fusions has emerged as one of the success stories of the targeted therapy era in non–small cell lung cancer ...
- Children's Cancer Institute announces new drug discovery project with Oncology Oneon August 24, 2021 at 5:00 pm
Australian biotech company, Oncology One Pty Ltd, has today announced a new partnership with Children’s Cancer Institute to develop new drugs for the treatment of childhood solid tumours. The ...
- Study could lead to new treatments for neuroblastomaon August 22, 2021 at 5:00 pm
In a recently completed study titled, “ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156,” that was published Aug ...
- Parents of Oscar Knox on fight to ensure his legacy lives on for many years to comeon August 22, 2021 at 4:19 am
"None of this will bring Oscar back but if we can make a difference for other children in the future, then that's something" ...
- Ethan’s Rodeo looks to raise awareness and funds for pediatric cancer researchon August 20, 2021 at 8:35 pm
Organizers David and Alicia Weiman said the inspiration for the event was their 4-year-old son Ethan who passed away in 2009 due to neuroblastoma, a rare form of cancer that mainly affects children.
via Google News and Bing News